aptazapine
≈ 2 min read
Names in other languages
- Englishaptazapine
- العربيةأبتازابين
- فارسیآپتازاپین
- shAptazapin
- СрпскиAptazapin
- 中文阿普氮平
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Aptazapine (developmental code name CGS-7525A) is a tetracyclic antidepressant (TeCA) that was assayed in clinical trials for the treatment of depression in the 1980s but was never marketed. It is a potent α 2 -adrenergic receptor antagonist with about 10 times the strength of the related compound mianserin and has also been shown to act as a 5-HT 2 receptor antagonist and H 1 receptor inverse agonist, while having no significant effects on the reuptake of serotonin or norepinephrine. Based on its pharmacological profile, aptazapine may be classified as a noradrenergic and specific serotonergic antidepressant (NaSSA).
Aptazapine (developmental code name CGS-7525A) is a tetracyclic antidepressant (TeCA) that was assayed in clinical trials for the treatment of depression in the 1980s but was never marketed. It is a potent α 2 -adrenergic receptor antagonist with about 10 times the strength of the related compound mianserin and has also been shown to act as a 5-HT 2 receptor antagonist and H 1 receptor inverse agonist, while having no significant effects on the reuptake of serotonin or norepinephrine. Based on its pharmacological profile, aptazapine may be classified as a noradrenergic and specific serotonergic antidepressant (NaSSA).
See also
Mianserin Mirtazapine Setiptiline
References
External links
Text derived from https://en.wikipedia.org/w/index.php?oldid=1329584248 under CC BY-SA 4.0; modifications have been made.